FoXX’s PRE-SEED ROUND IS NOW OPEN

INVEST IN THE FUTURE OF WOMEN'S HEALTH INFRASTRUCTURE

FoXX begins with a direct-to-consumer model, empowering women to track, understand, and articulate their symptoms with clarity. From there, we scale into clinical distribution through provider dashboards, health system integrations, and data-driven care tools.

Our roadmap moves deliberately:
 • Phase 1: DTC traction and retention
 • Phase 2: Wearable integration and premium tier expansion
 • Phase 3: Clinical sales and provider licensing

We have officially opened our pre-seed round and are speaking with aligned early investors.

Enter your details below to receive our investor deck outlining:
 – Market opportunity
 – Product roadmap
 – Monetization strategy (DTC > B2B clinical)
 – Exit strategy

We’ll follow up directly.

Building the future of women’s health intelligence

  • Massive unmet need

    93% of women report their symptoms are dismissed, and conditions like endometriosis, PCOS, and autoimmune disorders take years to diagnose. FoXX is tackling one of healthcare’s biggest gaps.

  • Data advantage & clinical credibility

    We’re officially licensed with the U.S. National Library of Medicine (UMLS, SNOMED CT, RxNorm, NIH CDEs, VSAC), giving FoXX access to the same medical standards providers use, and building a defensible moat.

  • First mover advantage

    While period trackers dominate the market, no one is addressing women’s whole-body health with the depth, inclusivity, and clinical credibility of FoXX.

  • Built with women, backed by doctors

    Our Advisory Committee of 100+ women, including patients, advocates, and healthcare providers, ensures FoXX is built on real needs and trusted medical standards.

  • Positioned for scale

    Women’s health is a $1 trillion+ market opportunity. With early adopter demand, brand partnerships, and a scalable product roadmap, FoXX is set to become the leading platform for women’s health clarity and advocacy.

  • A daily companion app with stickiness

    FoXX is designed for everyday use, creating habit-forming engagement that drives retention and lifetime value far beyond symptom logging apps.